Activity Dates: 05/15/2023 - 05/15/2026
We invite you to participate in this online course if you are a pharmacist, nurse, or other health care professional interested in administering and/or learning more about psychotropic long-acting injectables for patients living with serious mental illness or substance use disorders.
LAI Pocket Guide: Psychotropic Long-Acting Injectables
The pocket guide is a resource that pharmacists and other members of the health care team can easily access in practice to quickly locate key information on each of the available psychotropic LAIs. This information includes indications, formulations, pharmacokinetics, dosing, management of missed doses, how supplied, storage, and clinical pearls on preparation and administration. The pocket guide also contains QR codes and links to videos and additional information on product preparation and administration. Learners desiring a print copy can order directly here: Order a print copy! See the changelog below for what has changed in the latest update(s).
The LAI Pocket Guide is not intended to be a comprehensive source of drug information on these topics. The contents of this book should not be interpreted as official policy of the American Association of Psychiatric Pharmacists (AAPP) or an endorsement of any product(s). Nor should they be considered as a substitute for the professional judgement of practitioners and clinicians.
Last updated: July 19, 2023
This pocket guide is supported by educational grants from Alkermes Inc., Indivior Inc., and Janssen Scientific Affairs, LLC.
LAI Administration Videos
The administration videos help you visualize appropriate LAI injection techniques to perfect your administration and train team members. Administration videos are courtesy of SMI Adviser.
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
LAI Administrative Toolkit
The administrative toolkit contains helpful resources designed to assist with building and expanding LAI clinics, such as an appointment card, informed consent template, referral form, and communication letter between the pharmacist and prescriber.
The Administrative Toolkit is not intended to be a comprehensive source of information on these topics. The contents fo this toolkit should not be interpreted as official policy of the American Association of Psychiatric Pharmacists (AAPP) or an endorsement of any product(s). Nor should they be considered as a substitute for the professional judgement of practitioners and clinicians.
Last updated: May 2023
This toolkit is supported by educational grants from Alkermes Inc., Indivior Inc., and Janssen Scientific Affairs, LLC.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
Beth DeJongh, PharmD, BCPS, BCPP
Director of Continuing Professional Development
American Association of Psychiatric Pharmacists
No Relevant Financial Relationships to Disclose
Megan J. Ehret, PharmD, BCPP, MS
BCPP Program Director
University of Maryland
External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Saladex Biomedical Consultant,
SMI Adviser; Pharmacist Consultant
Educational Grants, Research Grants or Contracts: FDA/University of Maryland CERSI, Maryland Behavioral Health Department, NIH
All relevant relationships have been mitigated.
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information and disclosures). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.
This activity is supported by educational grants from Alkermes Inc., Indivior Inc., and Janssen Scientific Affairs, LLC.